Recurrent Pancreatic Carcinoma Active Not Recruiting Phase 1 Trials for Dasatinib (DB01254)

Also known as: Pancreatic carcinoma recurrent / Pancreas carcinoma recurrent / Pancreatic cancer recurrent

DBCOND0043478 (Recurrent Pancreatic Carcinoma)Active Not Recruiting1 IdentifierTitlePurposeDrugs
NCT01660971Gemcitabine Hydrochloride, Dasatinib, and Erlotinib Hydrochloride in Treating Patients With Pancreatic Cancer That Is Metastatic or Cannot Be Removed by SurgeryTreatment